Gilead Sciences (GILD)

EBITDA Growth

-87.84%

TTM · Period ending:

GILD logo

GILD EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-87.84%
GILD TTM EBITDA YoY % (-36.96% → -87.84%)
High-resolution chart · PNG

GILD ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Gilead Sciences EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-151.9951%
-42.7257%
28.8816%
55.9118%
38.3266%
37.2265%
16.1899%
-9.2338%
9.9545%
-51.0648%
-47.6636%
-60.3723%
-262.3529%
-42.1053%
-35.873%
-30.5556%
60.4651%
19.5767%
10%
-42.3841%
-28.1356%
-9.589%
-6.7138%
-11.7424%
-17.4797%
-32.7273%
-47.3958%
-61.9632%
-44.7059%
-77.4194%
-115.7303%
-158.7302%
-325%
-181.8182%
-97.7778%
-36.9565%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.